Gabapentin-induced severe myopathy

Annals of Pharmacotherapy

Volumn 41, Issue 7-8, 2007, Pages 1301-1305

  Tuccori, Marco ^a   Lombardo, Giuseppe ^b   Lapi, Francesco ^c   Vannacci, Alfredo ^c   Blandizzi, Corrado ^a   Del Tacca, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Hospital of Empoli   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Gabapentin; Myopathy; Neuropathic pain; Rhabdomyolysis

Indexed keywords

ACETYLSALICYLIC ACID; CREATINE KINASE; DILTIAZEM; GABAPENTIN; HALOPERIDOL; INSULIN; LANSOPRAZOLE; MYOGLOBIN; RAMIPRIL;

ACUTE KIDNEY FAILURE; AGED; AGITATION; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONVALESCENCE; CORONARY ARTERY DISEASE; DAILY LIFE ACTIVITY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC PATIENT; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; FEMALE; HISTOPATHOLOGY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LABORATORY TEST; LEG PAIN; MYALGIA; MYOPATHY; NARANJO PROBABILITY SCALE; NEUROPATHIC PAIN; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; RATING SCALE; RHABDOMYOLYSIS; STOMACH PAIN; TREATMENT OUTCOME; WALKING DIFFICULTY;

AGED, 80 AND OVER; AMINES; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MUSCULAR DISEASES; RHABDOMYOLYSIS;

EID: 34547208084     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1K077     Document Type: Article

References (22)

1. Baillie JK, Power I. The mechanism of action of gabapentin in neuropathic pain. Curr Opin Investig Drugs 2006;7:33-9.
2. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drag reactions. Clin Pharmacol Ther 1981;30:239-45.
3. Singh D, Chander V, Chopra K. Rhabdomyolysis. Methods Find Exp Clin Pharmacol 2005;27:39-48.
4. Yoshikawa H, Watanabe T, Abe T, Oda Y, Ozawa K. Haloperidol-induced rhabdomyolysis without neuroleptic malignant syndrome in a handicapped child. Brain Dev 2000;22:256-8.
5. Marinella MA. Rhabdomyolysis associated with haloperidol without evidence of NMS (letter). Ann Pharmacother 1997;31:927-8.
6. Clark DW, Strandell J. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors? Eur J Clin Pharmacol 2006;62:473-9.
7. Reeves RR, Mack JE, Torres RA. Neuroleptic malignant syndrome during a change from haloperidol to risperidone. Ann Pharmacother 2001;35:698-701. DOI 10.1345/aph.10137
8. Girard T, Samet S, Bianchi-Fior P, Gasnault J, Brivet F. Haloperidol, a new cause of rhabdomyolysis, in the absence of neuroleptic malignant syndrome. Presse Med 1994;23:1493.
9. Marsh SJ, Dolson GM. Rhabdomyolysis and acute renal failure during high-dose haloperidol therapy. Ren Fail 1995;17:467-78.
10. Smith JD, Chang KL, Gums JG. Possible lansoprazole-induced eosinophilic syndrome. Ann Pharmacother 1998;32:196-200. DOI 10.1345/aph.17190
11. Tuccori M, Giovannoni S, Giustini SE, Blandizzi C, Del Tacca M. Acute severe myopathy following a single infusion of omeprazole (letter). Ann Pharmacother 2006;40:352-3. Epub 27 Dec 2005. DOI 10.1345/aph.1G382
12. Anderlini P, Buzaid AC, Legha SS. Acute rhabdomyolysis after concurrent administration of interleukin-2, interferon-alfa, and chemotherapy for metastatic melanoma. Cancer 1995;76:678-9.
13. Boonen S, Van Distel G, Westhovens R, Dequeker J. Steroid myopathy induced by epidural triamcinolone injection. Br J Rheumatol 1995;34:385-6.
14. Ago M, Ago K, Hara K, Kashimura S, Ogata M. Toxicological and histopathological analysis of a patient who died nine days after a single intravenous dose of methamphetamine: a case report. Leg Med (Tokyo) 2006;8:235-9.
15. Kumar S. Steroid-induced myopathy following a single oral dose of prednisolone. Neurol India 2003;51:554-6.
16. Lipson J, Lavoie S, Zimmerman D. Gabapentin-induced myopathy in 2 patients on short daily hemodialysis. Am J Kidney Dis 2005;45:E100-4.
17. Bhanji NH. Serotonin syndrome following low-dose sertraline. Can J Psychiatry 2000;45:936-7.
18. Weffald LA, Flach LA. Myopathy associated with atorvastatin-ezetimibe combination therapy. Pharmacotherapy 2007;27:309-11.
19. Guis S, Mattel JP, Cozzone P, Bendahan D. Pathophysiology and clinical presentation of rhabdomyolysis. Joint Bone Spine 2005;72:382-91.
20. Cheng JK, Chiou LC. Mechanisms of the antinociceptive action of gabapentin. J Pharmacol Sci 2006;100:471-86.
21. Alden KJ, Garcia J. Differential effect of gabapentin on neuronal and muscle calcium currents. J Pharmacol Exp Ther 2001;297:727-35.
22. Liu Y, Qin N, Reitz T, Wang Y, Flores CM. Inhibition of the rat brain sodium channel Nav1.2 after prolonged exposure to gabapentin. Epilepsy Res 2006;70:263-8.